Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Shares Repurchased (2021 - 2025)

Definitive Healthcare's Shares Repurchased history spans 3 years, with the latest figure at $9.2 million for Q3 2025.

  • For Q3 2025, Shares Repurchased rose 14.77% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $49.5 million, up 121.1%, while the annual FY2025 figure was $49.5 million, 121.1% up from the prior year.
  • Shares Repurchased reached $9.2 million in Q3 2025 per DH's latest filing, down from $19.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $139.0 million in Q4 2021 to a low of $7.0 million in Q2 2024.
  • Average Shares Repurchased over 3 years is $30.1 million, with a median of $9.2 million recorded in 2025.
  • The largest YoY upside for Shares Repurchased was 172.4% in 2025 against a maximum downside of 14.77% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $139.0 million in 2021, then tumbled by 94.73% to $7.3 million in 2024, then increased by 25.82% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Shares Repurchased are $9.2 million (Q3 2025), $19.1 million (Q2 2025), and $21.2 million (Q1 2025).